These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20981593)

  • 41. Neoadjuvant Therapy for Rectal Cancer.
    Leeds IL; Fang SH
    Dis Colon Rectum; 2018 Aug; 61(8):883-886. PubMed ID: 29994956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rectal cancer: the good, the bad, and the ugly.
    Pricolo VE
    Arch Surg; 2011 May; 146(5):544. PubMed ID: 21739653
    [No Abstract]   [Full Text] [Related]  

  • 44. Optimal staging and treatment of localised rectal cancer.
    Påhlman L
    Ann Oncol; 2002; 13 Suppl 4():251-5. PubMed ID: 12401698
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results.
    Pucciarelli S; Friso ML; Toppan P; Fornasiero A; Carnio S; Marchiori E; Lise M
    Ann Surg Oncol; 2000; 7(1):38-44. PubMed ID: 10674447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accuracy of pre-treatment locoregional rectal cancer staging in a national improvement project.
    Op de Beeck B; Smeets P; Penninckx F; Pattyn P; Silversmit G; Van Eycken E;
    Acta Chir Belg; 2017 Apr; 117(2):104-109. PubMed ID: 27881048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
    Tanabe T; Shida D; Komukai S; Nakamura Y; Tsukamoto S; Kanemitsu Y
    BMC Cancer; 2019 Jul; 19(1):733. PubMed ID: 31340778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Staging of rectal cancer].
    Germer CT
    Chirurg; 2012 May; 83(5):421-2. PubMed ID: 22526932
    [No Abstract]   [Full Text] [Related]  

  • 50. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
    Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
    Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical diagnosis of cancer of the rectum].
    Adloff M
    Rev Prat; 1986 Sep; 36(41):2373-81. PubMed ID: 3491415
    [No Abstract]   [Full Text] [Related]  

  • 52. Determining the need for radical surgery in patients with T1 rectal cancer.
    Salinas HM; Dursun A; Klos CL; Shellito P; Sylla P; Berger D; Bordeianou L
    Arch Surg; 2011 May; 146(5):540-3. PubMed ID: 21576608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.
    Hakozaki Y; Sameshima S; Tatsuoka T; Okuyama T; Yamagata Y; Noie T; Oya M; Fujii A; Ueda Y; Shimura C; Katagiri K
    World J Surg Oncol; 2017 Aug; 15(1):160. PubMed ID: 28835241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic rectal adenocarcinoma and anal squamous cell carcinoma masquerading as vulvar lymphangioma circumscriptum.
    Soh JM; Scott GA; Pavlovitz BT; Mercurio MG
    J Obstet Gynaecol; 2016 Oct; 36(7):876-878. PubMed ID: 27616148
    [No Abstract]   [Full Text] [Related]  

  • 55. Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy.
    Lin AY; Wong WD; Shia J; Minsky BD; Temple LK; Guillem JG; Paty PB; Weiser MR
    Int J Colorectal Dis; 2008 Mar; 23(3):243-9. PubMed ID: 18046561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Surgical management of a retrorectal tumor with consideration of a rare differential diagnosis].
    Krückemeier K; Barth P; Peitz U; Hoffmann MW; Allemeyer EH
    Chirurg; 2012 Jul; 83(7):657-60. PubMed ID: 22653139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of carcinoembryonic antigen mRNA in peritoneal lavage determined by transcription-reverse transcription concerted method in patients with low rectal cancer.
    Murono K; Ishihara S; Kawai K; Kaneko M; Sasaki K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
    Asian J Surg; 2018 Jul; 41(4):321-327. PubMed ID: 28291565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.
    Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C
    Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.
    Wells SM; Boothe D; Ager BJ; Tao R; Gilcrease GW; Lloyd S
    Clin Colorectal Cancer; 2020 Jun; 19(2):91-99.e1. PubMed ID: 32173281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.